yourEra Reviews: A $249 NAD+ With No Route Named

The one-sentence version

yourEra publishes NAD+ from $249/mo with no long-term contract, no membership and no lab gate — one of the few headlines here that is not a prepay rate in disguise. What it never says is how the NAD+ is administered: no route, no dose, no protocol, no product page. It grades A, 12 out of 14, losing both pharmacy points, computed from published terms alone and blind to who pays us.

What it is, and who it's for

yourEra is a physician-directed compounded telehealth running four published programs: semaglutide from $99/mo, tirzepatide from $169/mo, microdosing protocols from $179/mo and NAD+ from $249/mo. A five-minute intake goes to a licensed provider in your state, and "if treatment is clinically appropriate, they issue a prescription filled by a state-licensed U.S. pharmacy." An optional tier, yourEra Optimum, is announced as coming soon and would add at-home lab draws, wearables, coaching and a nutritionist.

The buyer this suits wants a monthly figure with no contract behind it and is content to learn the clinical specifics after signing up. If you want the protocol described first, this is the wrong shape — see longevity clinics vs lab memberships.

What it actually costs

All figures verified on yourera.com on 26 July 2026.

The four published programs. Semaglutide from $99/mo, tirzepatide from $169/mo, microdosing protocols from $179/mo, NAD+ Anti-Aging from $249/mo.

The terms behind them are unusually clean. "Visit Included — Prescription & telehealth visit included." "One Price — Same price at every dose. No hidden fees." "Free Shipping — Free shipping from licensed US pharmacies." And on commitment: "Yes. There are no long-term contracts. Pause or cancel your program or Optimum membership from your patient portal at any time."

The dose guarantee is worth more than it sounds: titration repricing the plan is one of the standard ways these programs end up costing far more than the number that sold them, and yourEra rules it out in writing.

The word doing the work is "from." Every one of the four figures is a floor. No dose tiers, strengths or plan lengths are published beside them, so $249 is the cheapest configuration of the NAD+ program rather than its price. A "from" price at least cannot be lower than what you pay — but it cannot be checked either. Every "Get Started" link also points at intake.yourera.com with "promo=YourEra15" attached, so a discount code is pre-applied at every entry point; ask what the un-couponed rate is.

Refunds close at the pharmacy, not at delivery. The Refund Policy (last updated March 2026) states that once "your prescription has begun processing at the pharmacy, no refunds will be issued… whether or not it has shipped or been delivered." Before processing begins, "you may request a cancellation and full refund." A narrow window, stated plainly — more than several higher-priced competitors manage. See what longevity care costs.

The gap: nothing tells you what you are buying

This is the criticism that matters, and it is structural rather than fine print.

yourEra is a single-page site. There is no NAD+ product page — the treatments menu links to anchors on the homepage, and the entire published description of the program is a catalogue card reading "NAD+ Anti-Aging · from $249/mo" beside a navigation blurb reading "Cellular energy support for vitality and healthy aging." The route is never stated. Injection, nasal spray, sublingual, IV: the site does not say, and it publishes no strength, no dosing schedule and no definition of a month's supply.

The NAD+ intake link opens on a screen asking for your email address before anything else, so the first place the protocol is described is behind an account — a sequence that inverts what a $2,988-a-year purchase should look like. One related detail, published to yourEra's credit: "vial labels shown on this website are for marketing purposes only." The imagery is illustrative.

Clinical oversight and the pharmacy

Oversight is real and stated: a licensed provider in your state reviews the intake, "prescriptions are never automatic," and unlimited care-team messaging sits inside the program price — which earns the oversight and support points on our rubric. The brand also puts a named clinician's voice in public, under Dr Tom Lavin.

On pharmacy it says only "a state-licensed U.S. pharmacy," across both the FAQ and the footer. No facility, no address, no Section 503A or 503B claim — an unnamed network, which scores zero on our pharmacy factor.

What it does say about compounding is unusually candid, and it is the FDA's own framing rather than a softened version: "Compounded medications are prepared by state-licensed compounding pharmacies to a clinician's specifications. Compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality." That is exactly right¹, and most of this board will not print it.

The evidence behind what it sells

The NAD+ program is sold as "cellular energy support for vitality and healthy aging." Hedged, but a claim.

The 2026 PRISMA-guided systematic review of NAD+ for anti-aging and wellness screened 113 studies including 33 human intervention trials. Oral precursors reliably engage the target, but effects on functional, metabolic and vascular outcomes were "heterogeneous and often null or endpoint-specific," with clinical effectiveness "inconclusive." It also reported that no eligible outcomes trial has evaluated intravenous or intramuscular NAD+ for anti-aging or wellness indications at all² — which is impossible to apply here, because yourEra does not say which route it sells. A 2025 meta-analysis in adults averaging over 60 found NMN and NR did not improve muscle index, grip strength, gait speed or chair-stand time³, and the strongest randomised trial in the field moved six-minute walk distance about 17.6 metres in peripheral artery disease — a disease endpoint, not an aging one⁴. See NAD+ for longevity, do NAD+ peptides actually work and what's proven versus hyped.

The outcome statistics on the homepage — "-13.6% average body weight loss among YourEra members" — are labelled "based on self-reported data from YourEra members" and concern the GLP-1 programs, not NAD+. Self-reported data from people still enrolled is not a trial result, and yourEra labels it correctly.

Where it's weak, and who should skip it

Skip it if you need to know what you are injecting, spraying or swallowing before you pay — on NAD+, yourEra will not tell you until you are inside the intake. Skip it if $249 is a stretch: it is the top of this board's month-to-month range, and two A-graded competitors publish lower figures with the route stated.

If you proceed, ask three things before checkout: the route and strength of the protocol, what "from $249" becomes at your prescribed dose, and the price without the YourEra15 coupon.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). yourEra takes price transparency — one figure per program, published openly rather than quiz-gated, with what it covers named and no contract behind it — plus four for a real longevity line, two for the provider evaluation inside the price, and two for unlimited care-team messaging. It takes zero on pharmacy. Twelve of fourteen. An A.

The letter is honestly earned on billing and honestly incomplete on medicine. yourEra has done the hard part — a month-to-month price, a dose guarantee, no contract, an FDA-accurate compounding disclosure — and then declined to describe the product. Publish an NAD+ page with a route, a strength and a schedule and this becomes one of the easier recommendations here. The full graded field is at our provider rankings; two neighbours are our Strut Health review and Telos Rx review.